Microdosing Amanita muscaria for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Microdosing Amanita muscaria for Health & Longevity

Created on 06/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Small, sub-intoxicating doses of fly agaric mushroom, taken for calm, sleep, or mood. Its calming compound acts on the brain's main relaxation system, giving a believable way to work. Human evidence is almost absent — one case and scattered reports — while dosing is unreliable and serious poisonings, including deaths, are documented. (Full Review)

Protocol

Typical Dose
0.1–0.3 g dried
Reported microdose range; active-compound delivery at these weights is highly variable. Start well below any suggested amount and titrate slowly.
Form & Preparation
Dried, decarboxylated
Thorough drying or gentle heating converts ibotenic acid to the milder muscimol — the step most often described as essential.
Best Time of Day
Evening / pre-sleep
Most commonly reported, aligning with sleep- and calm-oriented goals; daytime dosing carries a higher impairment risk.
Time to effect
Acute Calm / Sedation
30 min – 2 h
Acute calming or sedating effects, when present, appear within roughly 30 minutes to 2 hours of a dose.
Mood / Sleep Benefit
Days to weeks
Any cumulative mood or sleep benefit reported anecdotally is described over days to weeks.
Full Reported Course
~3.5 months
The single published case study ran 3.5 months over a declining, intuition-based regimen.

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Epilepsy or other seizure disorders
  • Significant liver or kidney disease
  • Psychotic disorders
  • Concurrent sedatives, opioids, or other CNS depressants
  • Operating vehicles or machinery
  • Children
    •
Key Interactions
  • CNS depressants (benzodiazepines [diazepam, alprazolam], Z-drugs [zolpidem, zopiclone], barbiturates, opioids, alcohol)
  • Other GABAergic and sedating supplements (valerian, kava, high-dose magnesium, GABA supplements, L-theanine)
  • Over-the-counter sedating antihistamines (diphenhydramine, doxylamine)
  • Anticonvulsants and pro-convulsant agents
  • Anticholinergic and cholinergic drugs
    •

Risk & Side Effects

  • High: Dose unpredictability and risk of unintended intoxication; acute toxicity
    •
  • Medium: Gastrointestinal distress; excess sedation and next-day impairment
    •
  • Low: Cholinergic effects from muscarine; liver and kidney stress from contaminated or misidentified material
    •
  • Speculative: Dependence or tolerance; cumulative neurotoxicity from ibotenic acid; long-term effects
    •

Monitoring

Marker Target Why
ALT ~10–26 U/L Detects liver stress or injury
AST ~10–26 U/L Detects liver/tissue injury
eGFR >90 mL/min/1.73m² Assesses kidney filtration capacity
Bilirubin (total) ~0.3–1.0 mg/dL Marker of liver clearance function
CBC Within normal limits Screens general blood health and toxicity signs

Cadence: Baseline, then approximately every 3–6 months, with prompt evaluation after any episode of intoxication.

Qualitative Assessment

  • Sleep quality and time to fall asleep
  • Daytime anxiety and subjective calm
  • Mood and emotional resilience
  • Energy and next-day alertness (watch for grogginess as a sign of excess dose)
  • Cognitive clarity and coordination (impairment is an early intoxication sign)
  • Any gastrointestinal upset, twitching, or confusion (stop and seek care if present)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.